GlobeNewswire by notified

Scandinavian Tobacco Group A/S - Reduction of share capital

Share
Company Announcement
No. 21/2023

         Copenhagen, 25 May 2023

Scandinavian Tobacco Group A/S – Reduction of share capital

On 13 April 2023, the annual general meeting of Scandinavian Tobacco Group A/S (the "Company") resolved to adopt a proposal by the Board of Directors to reduce the Company’s share capital by nominally DKK 6,000,000 from nominally DKK 93,000,000 to nominally DKK 87,000,000 by cancelling some of the Company’s treasury shares. Today the Board of Directors has resolved to complete the capital reduction, and the reduction of the share capital has been registered with the Danish Business Authority.

Following the capital reduction, the Company’s share capital amounts to nominally DKK 87,000,000 divided into 87,000,000 shares of DKK 1 each. The total number of voting rights is 87,000,000.

The updated Articles of Association can be found on the Company’s website (www.st-group.com).


For further information, please contact:
Torben Sand, Head of Investor Relations and Communication
phone: +45 5084 7222 or torben.sand@st-group.com


About Scandinavian Tobacco Group

Scandinavian Tobacco Group A/S is a world-leading manufacturer of handmade and machine-rolled cigars with an annual production of more than four billion cigars. The Group holds market-leading positions in several categories and its products are sold in more than 100 markets.

Scandinavian Tobacco Group has its headquarters in Copenhagen, Denmark – and employs approximately 10,000 people in Europe, the US, Canada, the Dominican Republic, Honduras, Nicaragua, Indonesia and Sri Lanka. For more information please visit www.st-group.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

XBP Europe Awarded a Transformation Project for His Majesty’s Passport Office (HMPO)2.5.2024 14:30:15 CEST | Press release

LONDON, May 02, 2024 (GLOBE NEWSWIRE) -- XBP Europe (“XBP Europe” or the “Company”) (NASDAQ: XBP and XBPEW), today announced that the Company has been selected by His Majesty’s Passport Office (“HMPO”) as its technology and services partner on a nationwide project, which aims to make documents dating back to 1837 digitally available to the General Register Office (“GRO”). This multi-year contract in the UK has an approximate total contract value of $40 million. A duty to the public The GRO, part of HMPO, maintains the national archive of births, marriages and deaths for England and Wales. This project is one strand of a wider transformation programme for GRO to update its systems and services. With some records dating back to 1837, the GRO faces significant document quality issues, which complicates the process of making them digital. Varied record formats must be handled, paper records are often faded, and microfilm can be of poor quality. The solution XBP Europe will use its hyper au

Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med InterMail A/S' aktier2.5.2024 14:29:42 CEST | pressemeddelelse

Selskabsmeddelelse nr. 20 2023/24 2. maj 2024 Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med InterMail A/S' aktier InterMail A/S har dags dato modtaget meddelelser om transaktioner med selskabets aktier foretaget af ledende medarbejdere og/eller personer/selskaber der er nærtstående til disse. Der henvises til de vedhæftede filer. Venlig hilsen InterMail A/S Yderligere oplysninger: John Dueholm, Bestyrelsesformand Telefon: 31 24 49 31 E-mail: rdujdu@gmail.com InterMail er et datadrevet kommunikationshus, som rådgiver kunder i at skabe leads, salg samt øge kundeloyaliteten. Vi arbejder sammen med mere end 500 virksomheder, og hjælper dem med at skabe tydelige forretningsmæssige resultater på platforme som Google, Facebook, LinkedIn, Instagram samt via direct mails. Det kan vi fordi vi har erfarne og dygtige specialister med stor faglig ekspertise og mange års forretningsmæssig erfaring. Vedhæftede filer Selskabsmeddelelse 20 2023-24 - Indberetning af lede

Landsbankinn hf.: Financial results of Landsbankinn for the first three months of 20242.5.2024 14:25:23 CEST | Press release

Landsbankinn's net profit in the first three months of 2024 was ISK 7.2 billion.Return on equity (ROE) in the period was 9.3%, compared with 11.1% for the same period the previous year.The net interest margin was 2.9%. The net interest margin of domestic households was 2% and remains stable.Net interest income amounted to ISK 14.4 billion and net fee and commission income was ISK 2.7 billion.Net impairments were negative by ISK 2.7 billion and include an ISK 2.0 billion collective allowance against uncertainty related to natural disaster on the Reykjanes peninsula.The cost/income ratio was 33.6%, compared with 33.3% in the first quarter of 2023.The total capital ratio was 24.9% at the end of the period. The total capital requirement of the Financial Supervisory Authority of the Central Bank of Iceland is 20.7%.In March, Landsbankinn finalised the sale of green bonds in the amount of EUR 300 million, with subscriptions coming in at more than six times the size of the issuance.Also in Ma

Conqueror Freight Network brings together more than 120 logistics leaders from all over the world in Bali to celebrate its 10th Annual Meeting2.5.2024 14:08:15 CEST | Press release

Conqueror seized this special anniversary as an opportunity to recognize founding members with an Awards Ceremony and to present its new web app, its new website and cutting-edge digital services Bali, 2nd May 2024: Conqueror’s networking and conference event, from the 21st to the 23rd of April, came to a successful close last Wednesday. Conqueror Freight Network hosted professional leaders from the freight forwarding industry to discuss the global logistics environment, the industry challenges and growth and the technological trends in freight forwarding. The meeting that took place at the Intercontinental Bali Resort in Bali, Indonesia was attended by more than 120 freight forwarders from over 60 countries, facilitating their company’s increase, expansion and networking. In order to mark the 10th edition of Conqueror’s in-person conference, they presented an award honoring longstanding members who have been integral to the network since its inception, making invaluable contributions

Amolyt Pharma Granted FDA Fast Track Designation for Eneboparatide for the Treatment of Hypoparathyroidism2.5.2024 14:00:00 CEST | Press release

Designation reflects the seriousness of the disease and the potential for eneboparatide to address the urgent need for new treatment options that address key treatment goals in hypoparathyroidism LYON, France and CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that eneboparatide, its lead therapeutic peptide candidate in Phase 3 development for the treatment of hypoparathyroidism, has been granted fast track designation by the U.S. Food and Drug Administration (FDA). The FDA’s Fast Track process is designed to facilitate the development and expedite the review of new drugs to treat serious conditions with unmet medical needs, with the goal of introducing new treatment options to patients faster. “We believe FDA’s granting of fast track designation to eneboparatide reflects the agency’s recognition of the significant unmet needs that persist among pa

HiddenA line styled icon from Orion Icon Library.Eye